Cargando…

Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies

BACKGROUND: During the last few decades, patients’ rights have been reinforced in many countries by acts of law. Measures now include health care proxies to uphold the doctor-patient relationship and advance directives for end-of-life patients. These could be relevant tools as early as the initial d...

Descripción completa

Detalles Bibliográficos
Autores principales: Trarieux-Signol, Sophie, Moreau, Stéphane, Gourin, Marie-Pierre, Penot, Amélie, Edoux de Lafont, Geoffroy, Preux, Pierre-Marie, Bordessoule, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391307/
https://www.ncbi.nlm.nih.gov/pubmed/25859160
http://dx.doi.org/10.1186/1472-684X-13-57
_version_ 1782365803817992192
author Trarieux-Signol, Sophie
Moreau, Stéphane
Gourin, Marie-Pierre
Penot, Amélie
Edoux de Lafont, Geoffroy
Preux, Pierre-Marie
Bordessoule, Dominique
author_facet Trarieux-Signol, Sophie
Moreau, Stéphane
Gourin, Marie-Pierre
Penot, Amélie
Edoux de Lafont, Geoffroy
Preux, Pierre-Marie
Bordessoule, Dominique
author_sort Trarieux-Signol, Sophie
collection PubMed
description BACKGROUND: During the last few decades, patients’ rights have been reinforced in many countries by acts of law. Measures now include health care proxies to uphold the doctor-patient relationship and advance directives for end-of-life patients. These could be relevant tools as early as the initial diagnosis of haematological malignancies because of the uncertain disease course. The aim of this research was to assess the factors associated with the designation of a proxy and writing advance directives by patients in a haematology department in France. METHODS: After a specific programme to encourage discussions about end-of-life preferences, we conducted a mixed-methods study comprising retrospective analysis of a random sample of 200 patients’ medical records, crossed with a qualitative analysis of the content of advance directives. Statistical analysis was performed by the RKward V 0.6.1 software with 0.05 denoting significance. The study was performed and presented in accordance with the STROBE guidelines. A thematic analysis of the advance directives was performed by two researchers. RESULTS: A total of 197 medical records were evaluable. The mean age of the patients was 66 years (range: 18–91). Nearly 2/3 of them (64.5%) designated a proxy, 6.1% wrote advance directives, and 8.1% and 4.6% expressed a wish to meet a religious representative or a volunteer, respectively. The 2-year survival rate was 78.4% [95%CI: 68.2-90.2]. Patients who wrote advance directives were statistically older (p <0.00025). Patients who wrote an advance directive were more likely to have expressed a wish to meet a religious representative (p <0.001) or a volunteer (p = 0.003). Marital status was a significant factor in appointing a proxy (p = 0.04). CONCLUSIONS: To the best of our knowledge, this is the first paper to identify influencing factors for proxies and advance directives in a homogenous population of patients with haematological malignancies. Most patients chose a proxy. However, despite several training programmes for the carers and a care planning programme, few patients wrote advance directives. Our findings suggest that influencing factors are advanced age and a wish to see a religious representative. This study highlights the importance of oral communication about end-of-life issues between carers, patients and their relatives. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1472-684X-13-57) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4391307
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43913072015-04-10 Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies Trarieux-Signol, Sophie Moreau, Stéphane Gourin, Marie-Pierre Penot, Amélie Edoux de Lafont, Geoffroy Preux, Pierre-Marie Bordessoule, Dominique BMC Palliat Care Research Article BACKGROUND: During the last few decades, patients’ rights have been reinforced in many countries by acts of law. Measures now include health care proxies to uphold the doctor-patient relationship and advance directives for end-of-life patients. These could be relevant tools as early as the initial diagnosis of haematological malignancies because of the uncertain disease course. The aim of this research was to assess the factors associated with the designation of a proxy and writing advance directives by patients in a haematology department in France. METHODS: After a specific programme to encourage discussions about end-of-life preferences, we conducted a mixed-methods study comprising retrospective analysis of a random sample of 200 patients’ medical records, crossed with a qualitative analysis of the content of advance directives. Statistical analysis was performed by the RKward V 0.6.1 software with 0.05 denoting significance. The study was performed and presented in accordance with the STROBE guidelines. A thematic analysis of the advance directives was performed by two researchers. RESULTS: A total of 197 medical records were evaluable. The mean age of the patients was 66 years (range: 18–91). Nearly 2/3 of them (64.5%) designated a proxy, 6.1% wrote advance directives, and 8.1% and 4.6% expressed a wish to meet a religious representative or a volunteer, respectively. The 2-year survival rate was 78.4% [95%CI: 68.2-90.2]. Patients who wrote advance directives were statistically older (p <0.00025). Patients who wrote an advance directive were more likely to have expressed a wish to meet a religious representative (p <0.001) or a volunteer (p = 0.003). Marital status was a significant factor in appointing a proxy (p = 0.04). CONCLUSIONS: To the best of our knowledge, this is the first paper to identify influencing factors for proxies and advance directives in a homogenous population of patients with haematological malignancies. Most patients chose a proxy. However, despite several training programmes for the carers and a care planning programme, few patients wrote advance directives. Our findings suggest that influencing factors are advanced age and a wish to see a religious representative. This study highlights the importance of oral communication about end-of-life issues between carers, patients and their relatives. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1472-684X-13-57) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-11 /pmc/articles/PMC4391307/ /pubmed/25859160 http://dx.doi.org/10.1186/1472-684X-13-57 Text en © Trarieux-Signol et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Trarieux-Signol, Sophie
Moreau, Stéphane
Gourin, Marie-Pierre
Penot, Amélie
Edoux de Lafont, Geoffroy
Preux, Pierre-Marie
Bordessoule, Dominique
Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
title Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
title_full Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
title_fullStr Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
title_full_unstemmed Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
title_short Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
title_sort factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391307/
https://www.ncbi.nlm.nih.gov/pubmed/25859160
http://dx.doi.org/10.1186/1472-684X-13-57
work_keys_str_mv AT trarieuxsignolsophie factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies
AT moreaustephane factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies
AT gourinmariepierre factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies
AT penotamelie factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies
AT edouxdelafontgeoffroy factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies
AT preuxpierremarie factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies
AT bordessouledominique factorsassociatedwiththedesignationofahealthcareproxyandwritingadvancedirectivesforpatientssufferingfromhaematologicalmalignancies